CACCESE, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.676
AS - Asia 1.121
EU - Europa 802
SA - Sud America 312
AF - Africa 293
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 15
Totale 4.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.517
SG - Singapore 472
IT - Italia 256
BR - Brasile 195
CN - Cina 170
HK - Hong Kong 101
VN - Vietnam 98
DE - Germania 86
FI - Finlandia 54
PL - Polonia 39
NL - Olanda 37
BJ - Benin 33
GB - Regno Unito 31
CI - Costa d'Avorio 29
FR - Francia 26
CA - Canada 23
RU - Federazione Russa 23
AT - Austria 21
IN - India 21
MX - Messico 20
AR - Argentina 18
KR - Corea 18
TR - Turchia 17
AE - Emirati Arabi Uniti 16
SE - Svezia 16
DO - Repubblica Dominicana 14
IQ - Iraq 14
PE - Perù 14
PY - Paraguay 14
ZA - Sudafrica 14
EC - Ecuador 13
GA - Gabon 13
IE - Irlanda 12
UY - Uruguay 12
BA - Bosnia-Erzegovina 11
BE - Belgio 11
CO - Colombia 11
GH - Ghana 11
IR - Iran 11
JP - Giappone 11
LV - Lettonia 11
TN - Tunisia 11
CG - Congo 10
CL - Cile 10
CW - ???statistics.table.value.countryCode.CW??? 10
CZ - Repubblica Ceca 10
GF - Guiana Francese 10
GT - Guatemala 10
ID - Indonesia 10
IL - Israele 10
LB - Libano 10
LY - Libia 10
RO - Romania 10
SI - Slovenia 10
UA - Ucraina 10
ZM - Zambia 10
AO - Angola 9
BD - Bangladesh 9
BS - Bahamas 9
CU - Cuba 9
MD - Moldavia 9
NI - Nicaragua 9
NO - Norvegia 9
PK - Pakistan 9
SA - Arabia Saudita 9
SK - Slovacchia (Repubblica Slovacca) 9
YT - Mayotte 9
ZW - Zimbabwe 9
BO - Bolivia 8
EE - Estonia 8
ES - Italia 8
GE - Georgia 8
LU - Lussemburgo 8
MA - Marocco 8
ML - Mali 8
PS - Palestinian Territory 8
BY - Bielorussia 7
CH - Svizzera 7
CY - Cipro 7
EG - Egitto 7
GR - Grecia 7
HN - Honduras 7
HR - Croazia 7
JM - Giamaica 7
KG - Kirghizistan 7
LC - Santa Lucia 7
NG - Nigeria 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
TH - Thailandia 7
VE - Venezuela 7
YE - Yemen 7
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
CV - Capo Verde 6
GN - Guinea 6
IS - Islanda 6
KE - Kenya 6
NE - Niger 6
Totale 4.017
Salva come PNG Salva come JPEG
Città #
Ashburn 291
Singapore 270
Fairfield 138
Chandler 133
Hong Kong 93
Beijing 65
Seattle 64
Woodbridge 55
Cambridge 49
Houston 48
Wilmington 48
Los Angeles 45
Ann Arbor 42
New York 41
Ho Chi Minh City 33
Milan 33
Cotonou 32
Munich 32
Santa Clara 32
Padova 30
Abidjan 28
Boardman 28
Chicago 27
Helsinki 26
Rome 26
Bytom 23
Hanoi 23
São Paulo 23
Medford 16
Nuremberg 16
Princeton 16
Turku 15
Vienna 15
Buffalo 14
Hefei 14
San Diego 14
Libreville 13
Des Moines 12
Warsaw 12
Lappeenranta 11
Montevideo 11
The Dalles 11
London 10
Lusaka 10
Montreal 10
Salt Lake City 10
Seoul 10
Falkenstein 9
Luanda 9
Nassau 9
Accra 8
Brooklyn 8
Denver 8
Dublin 8
Harare 8
Managua 8
Riga 8
Santo Domingo 8
Bamako 7
Castries 7
Cayenne 7
Curitiba 7
Genoa 7
Havana 7
Johannesburg 7
Lima 7
San Francisco 7
Tampa 7
Tbilisi 7
Tokyo 7
Willemstad 7
Ankara 6
Baku 6
Bishkek 6
Bologna 6
Cagliari 6
Catania 6
Conakry 6
Dallas 6
Frankfurt am Main 6
Mexico City 6
Nairobi 6
Phoenix 6
Prague 6
Quito 6
Redondo Beach 6
Sarajevo 6
Sterling 6
Tripoli 6
Amman 5
Auckland 5
Belgrade 5
Brazzaville 5
Chennai 5
Dar es Salaam 5
Djibouti 5
Guatemala City 5
Kampala 5
Lilongwe 5
Luxembourg 5
Totale 2.363
Salva come PNG Salva come JPEG
Nome #
Valutazione dell'attività di pembrolizumab in pazienti con recidiva di glioma di alto-grado e perdita parziale o completa di espressione delle proteine del mismatch repair: studio monocentrico, osservazionale, prospettico 230
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 228
Anaplastic Astrocytoma: State of the art and future directions 200
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 188
Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter study 176
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 175
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 173
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 172
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 169
Clinical management of diffuse low-grade gliomas 164
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib 164
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 161
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities 156
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study 156
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience 149
Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients 142
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study 136
Phosphorylated acetyl-coa carboxylase is associated with clinical benefit with regorafenib in relapsed glioblastoma: REGOMA trial biomarker analysis 133
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study 126
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series 126
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 125
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study 113
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E-mutant and SOX2 amplification 113
PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review 109
Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma 99
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study 99
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care 95
Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain 93
Local therapy in glioma: An evolving paradigm from history to horizons (Review) 79
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study 31
Totale 4.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.238
article - articoli 13.807
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 10 23 27 32 9 31 9
2021/2022240 9 6 23 15 8 15 31 18 43 3 14 55
2022/2023235 36 33 8 29 27 26 1 20 31 7 15 2
2023/2024242 6 29 22 17 17 45 34 15 8 7 21 21
2024/20251.014 4 64 40 32 79 56 72 94 99 86 193 195
2025/20262.156 254 308 462 710 415 7 0 0 0 0 0 0
Totale 4.280